Erratum: HIV-host interactions: Vital to the virus and key to its inhibition (Current Opinion in Microbiology (2004) 7:4 PII: S1369-5274(04)00068- 2) and DOI: 10.1016/j.mib.2004.06.002;HIV-host interactions: Vital to the virus and key to its inhibition

Current Opinion in Microbiology

Volumn 7, Issue 4, 2004, Pages 407-411

  Trkola, Alexandra ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHILIN A; NEF PROTEIN; REV PROTEIN; TRANSACTIVATOR PROTEIN; VIRUS PROTEIN;

HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LIFE CYCLE; NONHUMAN; REVERSE TRANSCRIPTION; REVIEW; VIROGENESIS; VIRUS CELL INTERACTION; VIRUS TRANSCRIPTION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 4143098020     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mib.2004.08.001     Document Type: Erratum

References (37)

1. T.C. Pierson, and R.W. Doms HIV-1 entry and its inhibition Curr Top Microbiol Immunol 281 2003 1 27
2. F. Cocchi, A.L. DeVico, A. Garzino-Derno, S.K. Arya, R.C. Gallo, and P. Lusso Identification of RANTES, MIP-1 alpha and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells Science 270 1995 1811 1815
3. Y. van Kooyk, and T.B. Geijtenbeek DC-SIGN: escape mechanism for pathogens Nat Rev Immunol 3 2003 697 709
4. M.D. Bobardt, A.C. Saphire, H.C. Hung, X. Yu, S.B. Van der, Z. Zhang, G. David, and P.A. Gallay Syndecan captures, protects, and transmits HIV to T lymphocytes Immunity 18 2003 27 39
5. J.D. Dvorin, and M.H. Malim Intracellular trafficking of HIV-1 cores: journey to the center of the cell Curr Top Microbiol Immunol 281 2003 179 208
6. E.K. Franke, H.E. Yuan, and J. Luban Specific incorporation of cyclophilin A into HIV-1 virions Nature 372 1994 359 362
7. D. Braaten, C. Aberham, E.K. Franke, L. Yin, W. Phares, and J. Luban Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A J Virol 70 1996 5170 5176
8. G.J. Towers, T. Hatziioannou, S. Cowan, S.P. Goff, J. Luban, and P.D. Bieniasz Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors Nat Med 9 2003 1138 1143 This study unravels the action of CypA in human and simian cells. It is found to counteract the human restriction factor Ref1 by binding to HIV-1 capsid protein, thus promoting HIV-1 infection, whereas the same interaction supports sensitivity to the simian restriction factor Lv1.
9. M. Stremlau, C.M. Owens, M.J. Perron, M. Kiessling, P. Autissier, and J. Sodroski The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys Nature 427 2004 848 853 This study identifies TRIM5α as the long-sought innate restriction factor in simian cells that blocks HIV-1 infection.
10. J.H. Simon, N.C. Gaddis, R.A. Fouchier, and M.H. Malim Evidence for a newly discovered cellular anti-HIV-1 phenotype Nat Med 4 1998 1397 1400
11. N.C. Gaddis, E. Chertova, A.M. Sheehy, L.E. Henderson, and M.H. Malim Comprehensive investigation of the molecular defect in vif-deficient human immunodeficiency virus type 1 virions J Virol 77 2003 5810 5820
12. A.M. Sheehy, N.C. Gaddis, J.D. Choi, and M.H. Malim Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein Nature 418 2002 646 650 First identification of APOBEC3G as the human factor that restricts HIV-1 infectivity in the absence of Vif.
13. •].
14. D. Lecossier, F. Bouchonnet, F. Clavel, and A.J. Hance Hypermutation of HIV-1 DNA in the absence of the Vif protein Science 300 2003 1112
15. B. Mangeat, P. Turelli, G. Caron, M. Friedli, L. Perrin, and D. Trono Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts Nature 424 2003 99 103
16. H. Zhang, B. Yang, R.J. Pomerantz, C. Zhang, S.C. Arunachalam, and L. Gao The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA Nature 424 2003 94 98
17. •].
18. •].
19. •].
20. •].
21. •], that independently characterize how Vif blocks the antiviral effects of APOBEC3G.
22. W.C. Greene, and B.M. Peterlin Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy Nat Med 8 2002 673 680
23. D. McDonald, M.A. Vodicka, G. Lucero, T.M. Svitkina, G.G. Borisy, M. Emerman, and T.J. Hope Visualization of the intracellular behavior of HIV in living cells J Cell Biol 159 2002 441 452
24. A. Fassati, D. Gorlich, I. Harrison, L. Zaytseva, and J.M. Mingot Nuclear import of HIV-1 intracellular reverse transcription complexes is mediated by importin 7 EMBO J 22 2003 3675 3685 Identification of importin 7 as an essential factor in HIV-1 nuclear import.
25. A.R. Schroder, P. Shinn, H. Chen, C. Berry, J.R. Ecker, and F. Bushman HIV-1 integration in the human genome favors active genes and local hotspots Cell 110 2002 521 529 The authors demonstrate that HIV integration is not a random process because HIV provirus integrates preferentially at transcriptionally active spots of the host DNA, thereby profiting from the chromosomal milieu.
26. L.A. Pereira, K. Bentley, A. Peeters, M.J. Churchill, and N.J. Deacon A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter Nucleic Acids Res 28 2000 663 668
27. K.A. Jones, and B.M. Peterlin Control of RNA initiation and elongation at the HIV-1 promoter Annu Rev Biochem 63 1994 717 743
28. K. Strebel Virus-host interactions: role of HIV proteins Vif, Tat, and Rev AIDS 17 2003 S25 S34
29. L. Ganesh, E. Burstein, A. Guha-Niyogi, M.K. Louder, J.R. Mascola, L.W. Klomp, C. Wijmenga, C.S. Duckett, and G.J. Nabel The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes Nature 426 2003 853 857 Murr1, a protein that is involved in copper homeostasis, inhibits proteosomal degradation of IκB and thus augments NF-κB retention in the cytoplasm. This activity of Murr1 seems to be largely responsible for the impaired replication of HIV-1 in resting T cells.
30. D. Daelemans, E. Afonina, J. Nilsson, G. Werner, J. Kjems, E. de Clercq, G.N. Pavlakis, and A.M. VanDamme A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export Proc Natl Acad Sci USA 99 2002 14440 14445
31. J.L. Anderson, and T.J. Hope Recent Insights into HIV Accessory Proteins Curr Infect Dis Rep 5 2003 439 450
32. C. Zimmerman, K.C. Klein, P.K. Kiser, A.R. Singh, B.L. Firestein, S.C. Riba, and J.R. Lingappa Identification of a host protein essential for assembly of immature HIV-1 capsids Nature 415 2002 88 92
33. J. Martin-Serrano, T. Zang, and P.D. Bieniasz HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress Nat Med 7 2001 1313 1319
34. J.E. Garrus, U.K. von Schwedler, O.W. Pornillos, S.G. Morham, K.H. Zavitz, H.E. Wang, D.A. Wettstein, K.M. Stray, M. Cote, and R.L. Rich Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding Cell 107 2001 55 65
35. •].
36. •], revealed that AIP1 binds HIV-1 p6 and, together with Tsg-101, is crucially involved in orchestrating HIV-1 budding.
37. D.G. Demirov, A. Ono, J.M. Orenstein, and E.O. Freed Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function Proc Natl Acad Sci USA 99 2002 955 960